Market Overview:
The global cell counters market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for automated cell counters and rising prevalence of chronic diseases. The global cell counters market is segmented by type, application, and region. By type, the market is divided into automated cell counters and manual cell counters. Automated cell counter held a larger share of the global market in 2017 owing to its advantages such as accuracy and speed over manual counting methods. By application, research institutes accounted for the largest share of the global market in 2017 followed by hospitals, clinical laboratories, pharmaceuticals & biotechnology companies, and others respectively.
Product Definition:
Cell Counters are instruments used to count the number of cells in a suspension. The importance of Cell Counters is that they allow researchers to accurately measure the cell concentration in a sample, which is necessary for many experiments.
Automated Cell Counters:
Automated cell counters are used to measure the total number of cells in a sample. It is an important tool for measuring and analyzing biological or cellular parameters such as density, size, volume, and surface area of living organisms. The automated counters help in counting the total number of cells present in a given amount of time under specified conditions.
Manual Cell Counters:
Manual cell counters are used to measure the number of cells in a specific region or volume. It is an inexpensive and easy-to-use device that helps healthcare professionals count the number of cells present in a sample. The manual cell counter is considered as one of the most important tools for analyzing biological samples because it provides more accurate results than other methods such as trypan blue dyeing method, which can be used to estimate total cell numbers but gives an imprecise result.
Application Insights:
The research institutes segment dominated the global cell counters market in 2017. This is attributed to the rising number of R&D activities being carried out in various institutions across the world. For instance, as per a 2016 article published by Cellomics, Institute of Cancer Research has more than 200 researchers working on different projects related to cancer genomics and proteomics. In addition, according to data published by NCBI in 2018, National Cancer Center Japan has around 1,000 researchers working on different projects related to cancer biology and treatment options. Such factors are anticipated to contribute towards revenue growth during the forecast period.
Clinical laboratories accounted for a significant share within this segment owing to an increase in demand for faster diagnostic tests with higher specificity.
Regional Analysis:
North America dominated the global market in 2017. The presence of major players, advanced healthcare infrastructure and high adoption rate for technologically advanced products are some of the factors contributing to its growth. Moreover, increasing government funding for R&D activities is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by governments and private companies in order to improve diagnosis rates and develop new therapies for diseases affecting large populations across this region. Rising awareness among people regarding early disease detection will further propel regional growth during the forecast years 2018 through 2030. In addition, growing medical tourism industry due to affordable treatment options will also boost demand over the next eight years 2030 CE in Asia Pacific cell counters market space’s developing countries such as India China Japan South Korea Thailand Malaysia Indonesia Philippines Vietnam Myanmar (Burma) Singapore Bangladesh Iran Pakistan Ethiopia Russia Saudi Arabia United Arab Emirates (UAE).
Growth Factors:
- Increasing demand for cell counting in research and development activities
- Rising prevalence of cancer and other diseases that require cell counting for diagnosis and treatment
- Technological advancements in cell counters that offer enhanced accuracy and efficiency
- Growing number of blood donation centers and tissue banks across the globe
- Increasing awareness about the benefits of using automated cell counters
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Counters Market Research Report
By Type
Automated Cell Counters, Manual Cell Counters
By Application
Research Institutes, Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Others
By Companies
Thermo Fisher Scientific, Bio-Rad, Beckman Coulter, Countstar, Merck Millipore, Roche Diagnostics, ViroCyt, ChemoMetec, Nexcelom, Agilent, Thermo Fisher Scientific, Warner Instruments, Molecular Devices, New Brunswick Scientific, Sysmex, Dynalon, Oxford Optronix, Danaher, Becton, Dickinson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
211
Number of Tables & Figures
148
Customization Available
Yes, the report can be customized as per your need.
Global Cell Counters Market Report Segments:
The global Cell Counters market is segmented on the basis of:
Types
Automated Cell Counters, Manual Cell Counters
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Institutes, Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Bio-Rad
- Beckman Coulter
- Countstar
- Merck Millipore
- Roche Diagnostics
- ViroCyt
- ChemoMetec
- Nexcelom
- Agilent
- Thermo Fisher Scientific
- Warner Instruments
- Molecular Devices
- New Brunswick Scientific
- Sysmex
- Dynalon
- Oxford Optronix
- Danaher
- Becton, Dickinson
Highlights of The Cell Counters Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Automated Cell Counters
- Manual Cell Counters
- By Application:
- Research Institutes
- Hospitals
- Clinical Laboratories
- Pharmaceutical and Biotechnology Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Counters Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell Counters is a software application that helps you keep track of the number of active and inactive cells in your device's memory.
Some of the major players in the cell counters market are Thermo Fisher Scientific, Bio-Rad, Beckman Coulter, Countstar, Merck Millipore, Roche Diagnostics, ViroCyt, ChemoMetec, Nexcelom, Agilent, Thermo Fisher Scientific, Warner Instruments, Molecular Devices, New Brunswick Scientific, Sysmex, Dynalon, Oxford Optronix, Danaher, Becton, Dickinson.
The cell counters market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Counters Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell Counters Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell Counters Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell Counters Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell Counters Market Size & Forecast, 2020-2028
4.5.1 Cell Counters Market Size and Y-o-Y Growth
4.5.2 Cell Counters Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Automated Cell Counters
5.2.2 Manual Cell Counters
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research Institutes
6.2.2 Hospitals
6.2.3 Clinical Laboratories
6.2.4 Pharmaceutical and Biotechnology Companies
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell Counters Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell Counters Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Automated Cell Counters
9.6.2 Manual Cell Counters
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research Institutes
9.10.2 Hospitals
9.10.3 Clinical Laboratories
9.10.4 Pharmaceutical and Biotechnology Companies
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Automated Cell Counters
10.6.2 Manual Cell Counters
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research Institutes
10.10.2 Hospitals
10.10.3 Clinical Laboratories
10.10.4 Pharmaceutical and Biotechnology Companies
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Automated Cell Counters
11.6.2 Manual Cell Counters
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research Institutes
11.10.2 Hospitals
11.10.3 Clinical Laboratories
11.10.4 Pharmaceutical and Biotechnology Companies
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Automated Cell Counters
12.6.2 Manual Cell Counters
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research Institutes
12.10.2 Hospitals
12.10.3 Clinical Laboratories
12.10.4 Pharmaceutical and Biotechnology Companies
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Automated Cell Counters
13.6.2 Manual Cell Counters
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research Institutes
13.10.2 Hospitals
13.10.3 Clinical Laboratories
13.10.4 Pharmaceutical and Biotechnology Companies
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell Counters Market: Competitive Dashboard
14.2 Global Cell Counters Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Bio-Rad
14.3.3 Beckman Coulter
14.3.4 Countstar
14.3.5 Merck Millipore
14.3.6 Roche Diagnostics
14.3.7 ViroCyt
14.3.8 ChemoMetec
14.3.9 Nexcelom
14.3.10 Agilent
14.3.11 Thermo Fisher Scientific
14.3.12 Warner Instruments
14.3.13 Molecular Devices
14.3.14 New Brunswick Scientific
14.3.15 Sysmex
14.3.16 Dynalon
14.3.17 Oxford Optronix
14.3.18 Danaher
14.3.19 Becton, Dickinson
